New hope for kids battling untreatable TB

NCT ID NCT02354014

Recruiting now Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

Summary

This study aims to see if a drug called bedaquiline is safe and works well for children and teenagers with a hard-to-treat form of tuberculosis (MDR-TB). Researchers will give bedaquiline along with other standard TB drugs to up to 60 participants, from newborns to under 18 years old. The main goals are to check for side effects and to understand how the child's body processes the drug.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

De La Salle Health Sciences Institute- DLSUMC
RECRUITING

Dasmariñas, 4114, Philippines
Desmond Tutu TB Centre
RECRUITING

Stellenboch, 7600, South Africa
First Moscow State Medical University n.a. I.M. Sechenov
COMPLETED

Moscow, 119991, Russia
Hospital Geral da Polana Caniço
RECRUITING

Maputo, 00000, Mozambique
Lung Center Of The Philippines
COMPLETED

Quezon City, 1100, Philippines
Makerere University Lung Institute
TERMINATED

Kampala, Uganda
Silang Specialists Medical Center
RECRUITING

San Vincent Silang, 000, Philippines
Sizwe Tropical Diseases Hospital
RECRUITING

Johannesburg, 2131, South Africa
State Institute Of Phthisiology And Pulmonology N.A. F.G. Yanovskiy Of Ams Ukraine
COMPLETED

Kiev, 3038, Ukraine
THINK: Tuberculosis & HIV Investigative Network
COMPLETED

Durban, 4001, South Africa
Wits Health Consortium
RECRUITING

Port Elizabeth, 6200, South Africa

Conditions

Explore the condition pages connected to this study.

MULTIDRUG-RESISTANT TUBERCULOSIS TUBERCULOSIS, MULTIDRUG-RESISTANT